Knowledge Distillery

Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms

Acute ischemic stroke and COVID-19: An analysis of 27 676 Patients

Inflammatory cytokine patterns associated with neurological diseases in COVID-19

Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-6

Neurological manifestations as primary presentation of COVID-19 in hospitalized patients

COVID-19 presentations and outcome in patients with epilepsy

Acute‐onset delirium in intensive care COVID patients: association of imperfect brain repair with foodborne micro‐pollutants

Global absence and targeting of protective immune states in severe COVID-19

Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United…

Assessing brain capillaries in coronavirus disease 2019

Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study

Stroke acute management and outcomes during the COVID-19 outbreak: A cohort study from the Madrid stroke network